Academic literature on the topic 'Fengycine'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fengycine.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Fengycine"
Blacutt, A. A., T. R. Mitchell, C. W. Bacon, and S. E. Gold. "Bacillus mojavensis RRC101 Lipopeptides Provoke Physiological and Metabolic Changes During Antagonism Against Fusarium verticillioides." Molecular Plant-Microbe Interactions® 29, no. 9 (September 2016): 713–23. http://dx.doi.org/10.1094/mpmi-05-16-0093-r.
Full textPapadopoulou, Evgenia-Anna, Apostolis Angelis, Lemonia Antoniadi, Konstantinos A. Aliferis, and Alexios-Leandros Skaltsounis. "Discovering the Next-Generation Plant Protection Products: A Proof-of-Concept via the Isolation and Bioactivity Assessment of the Olive Tree Endophyte Bacillus sp. PTA13 Lipopeptides." Metabolites 11, no. 12 (December 2, 2021): 833. http://dx.doi.org/10.3390/metabo11120833.
Full textMeena, Khem Raj, and Shamsher S. Kanwar. "Lipopeptides as the Antifungal and Antibacterial Agents: Applications in Food Safety and Therapeutics." BioMed Research International 2015 (2015): 1–9. http://dx.doi.org/10.1155/2015/473050.
Full textLv, Jia, Rong Da, Yue Cheng, Xiaohong Tuo, Jie Wei, Kaichong Jiang, Adediji Omolade Monisayo, and Bei Han. "Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile." BioMed Research International 2020 (March 4, 2020): 1–12. http://dx.doi.org/10.1155/2020/3104613.
Full textZeriouh, Houda, Diego Romero, Laura García-Gutiérrez, Francisco M. Cazorla, Antonio de Vicente, and Alejandro Pérez-García. "The Iturin-like Lipopeptides Are Essential Components in the Biological Control Arsenal of Bacillus subtilis Against Bacterial Diseases of Cucurbits." Molecular Plant-Microbe Interactions® 24, no. 12 (December 2011): 1540–52. http://dx.doi.org/10.1094/mpmi-06-11-0162.
Full textFu, Ruimin, Hong Zhang, Wei Tang, Xue Yang, Ding Wang, and Wuling Chen. "Study on the effect of fengycin on the respiration and metabolic mechanism of Penicillium expansum." Materials Express 11, no. 12 (December 1, 2021): 2047–51. http://dx.doi.org/10.1166/mex.2021.2114.
Full textWise, Cody, Justin Falardeau, Ingrid Hagberg, and Tyler J. Avis. "Cellular Lipid Composition Affects Sensitivity of Plant Pathogens to Fengycin, an Antifungal Compound Produced by Bacillus subtilis Strain CU12." Phytopathology® 104, no. 10 (October 2014): 1036–41. http://dx.doi.org/10.1094/phyto-12-13-0336-r.
Full textLu, Hedong, Hai Xu, Panping Yang, Muhammad Bilal, Shaohui Zhu, Mengyuan Zhong, Li Zhao, et al. "Transcriptome Analysis of Bacillus amyloliquefaciens Reveals Fructose Addition Effects on Fengycin Synthesis." Genes 13, no. 6 (May 31, 2022): 984. http://dx.doi.org/10.3390/genes13060984.
Full textTomashevich, N. S., T. M. Sidorova, V. V. Allahverdyan, and A. M. Asaturova. "The study of metabolites of new promising strains of bacterial‐antagonists of the genus <i>Bacillus</i> to increase the effectiveness of fungicidal biological products based on them." South of Russia: ecology, development 18, no. 2 (July 11, 2023): 70–81. http://dx.doi.org/10.18470/1992-1098-2023-2-70-81.
Full textFu, Ruimin, Wei Tang, Hong Zhang, Yulian Zhang, Ding Wang, and Wuling Chen. "Study on the mechanism of inhibiting patulin production by fengycin." Open Life Sciences 17, no. 1 (January 1, 2022): 372–79. http://dx.doi.org/10.1515/biol-2022-0041.
Full textDissertations / Theses on the topic "Fengycine"
Yaseen, Yazen Mohlab. "Fengycin production by strains of bacillus : molecular and physiological aspects." Thesis, Lille 1, 2016. http://www.theses.fr/2016LIL10062/document.
Full textThis work aimed at analyzing the overproduction of fengycin in Bacillus subtilis BBG21 and then was compared to a set of Bacilli strains. As BBG21 also produces surfactin, we also studied coproduction of lipopeptides in this strain. The work highlighted the role the promotor Pfen and Ppps in the synthesis of fengicins. The analysis of sequences was unveiled 10 missing nucleotides between Ppps168 and PfenBBG21 and modification of one nucleotide of the UP element between strains BBG21 and 21332, respectively. Secondly, environmental conditions that might influence the promotor Pfen expression and synthesis of both lipopeptides were also tested in B. subtilis BBG 208. Thus, carbon sources appeared to direct synthesis of one family of lipopeptides, whilst most of nitrogen sources allowed high level of both lipopeptides co-synthesis. A strong expression of promotor Pfen and an important synthesis of fengycins were obtained with urea or urea ammonium mixture used as nitrogen source and with mannitol as carbon source. Temperature, pH and filling volume are important for fengycins synthesis and these conditions are carbon and nitrogen sources dependent. Finally we studied fengycins synthesis in surfactin and PNPase mutants derived from Bs 168. The result showed that srfAA regulator decreased fengycin synthesis whereas srfAC has not any affect. Notably, an important decrease in surfactin and fengycin was observed for PNPase mutant strains
Chtioui, Omar. "Production sélective de lipopeptides par Bacillus subtilis en bioréacteur à disques tournants." Thesis, Lille 1, 2011. http://www.theses.fr/2011LIL10162/document.
Full textBacillus subtilis ATCC 21332 produces two families of lipopeptides (surfactins and fengycins/plipastatins) with different biological properties of interest. The productivity of fermentation process in batch or continuous conditions and bioreactors scale-up are limited by the problems of oxygen transfer limitation and foaming. This work presents a novel process of non-foaming production of lipopeptides in a rotating discs bioreactor and pertraction studies on the recovery of lipopeptides from fermentation broth. The improving production of lipopeptides by B. subtilis immobilized on solid supports enabled the implementation of an original bubbleless bioreactor for a selective production of lipopeptides. More than 1 g L-1 of lipopeptides was produced in this new rotating discs bioreactor. The oxygen transfer, a key factor for the metabolism of B. subtilis, was studied, also. In every studied configuration of bioreactor, the transfer of oxygen was strongly affected by the agitation conditions. At KLa in the range of 0.001-0.003 s-1, mainly fengycin was produced (up to 80% of total lipopeptides). The obtained high fengycin selectivity and the simplicity of the implementation of the rotating discs bioreactor suggest its potential scale-up. The extraction of lipopeptides by pertraction in a rotating discs contactor was studied, also. The obtained results on surfactin recovery by pertraction allow to consider this technique as suitable for lipopeptides extraction from fermentation broth
Hussein, Amin Mohamed Abdelwahed Walaa. "Study on the regulation and biosynthesis of fengycin and plipastatin produced by Bacillus subtilis." Thesis, Lille 1, 2011. http://www.theses.fr/2011LIL10024/document.
Full textIn this study, 36 Bacillus strain genomes were analyzed; nine of them have no NRPS molecules while the detection of one NRPS molecule ‘Bacillibactin siderophore’ was showed for another nine strains. The other 18 strains showed the presence of 17 other new NRPS and NRPS-PKS hybrid molecules. The analysis of plipastatin or fengycin operons sequences of Bs F29-3, Bs 168 and B. amyloliqufaciens FZB42 were studied, which refer to the similarity of these molecules and clarified the importance of sequencing the Bs S499 fengycin operon which have a fengycin molecule cannot be correlated with the structure of the synthetases described in other fengycin- or plipastatin-producing strains interesting to come over the difficulty of the differentiation between fengycin and plipastatin. The obtaining of plipastatin mono-producer derivative from Bs 168 by the replacement of the plipastatin native promoter by a constitutive one Prepu was failed. The constructed plasmid with Prepu-neo gene have two types; pBG180 which couldn’t be transformed and pBG180* which has inverted Prepu-neo gene and transformed into BBG111 to obtain BBG140 which showed no plipastatin production and high surfactin production than the mother strain BBG111. The expression and the regulation of Ppps, Pfen and Psrf were studied in Bs 168 derivatives: BBG142, BBG139 and BBG127 respectively
Leconte, Aline. "Activité antifongique de lipopeptides de Bacillus subtilis sur une souche de Venturia inaequalis (tavelure du pommier) de sensibilité réduite aux triazoles : contribution à la compréhension du mode d'action." Electronic Thesis or Diss., Université de Lille (2022-....), 2024. http://www.theses.fr/2024ULILR031.
Full textThe fight against apple scab caused by Venturia inaequalis, a harmful disease, requires more environmentally friendlier alternatives to conventional chemical fungicides. One promising possibility is the use of lipopeptides produced by various Bacillus species. One of the objectives of this work was to evaluate the efficacy of three families of lipopeptides (fengycins, iturins and surfactins) and their mixtures in controlling V. inaequalis, both in vitro and in vivo. The project was based on a V. inaequalis strain sensitive to tebuconazole (S755) and a strain with reduced sensitivity to tebuconazole (Rs552), which also exhibit differential resistance to fengycin, with the aim of deepening the understanding of the mechanisms responsible for this difference in sensitivity to these two antifungal treatments. Unlike fengycin, lipopeptides from the iturin family have a similar activity on both strains, while those from the surfactin family are not active, except in binary mixtures with fengycin. Mixtures of fengycin/surfactin 50-50% and mycosubtilin/surfactin 80-20% are as effective as individual lipopeptides in vitro. From these mixtures, orchard trials have shown a significant reduction in scab incidence of up to 70%. Sensitivity differences were investigated using molecular biology, microscopy and lipidomic techniques. Sensitivity differences to triazole are related to distinct molecular mechanisms, including overexpression of the Cyp51A gene and increased efflux by membrane pumps in the Rs552 strain. Whereas these mechanisms do not seem to be involved in reduced sensitivity to fengycin. Microscopic observations indicate cellular alterations induced by fengycin, suggesting an interaction with plasma membranes. Lipid analyses reveal some variations in sterol and total fatty acid composition as well as phospholipids between strains, which could influence their sensitivity to fengycin. In conclusion, the potential effectiveness of lipopeptides produced by Bacillus as an alternative to chemical fungicides in the biocontrol of apple scab has been highlighted
Glazyrina, Julia [Verfasser], Peter [Akademischer Betreuer] Neubauer, Peter [Gutachter] Neubauer, Peter [Gutachter] Götz, and Vera [Gutachter] Meyer. "Endophytes as source of polypeptide and polyketide antibiotics fengycin and bacillaene : process development for fengycin production / Julia Glazyrina ; Gutachter: Peter Neubauer, Peter Götz, Vera Meyer ; Betreuer: Peter Neubauer." Berlin : Technische Universität Berlin, 2018. http://d-nb.info/1156331099/34.
Full textFaria, Andréia Fonseca de. "Produção, purifucação e caracterização química de biossurfactantes produzidos por Bacillus subtilis em glicerina residual." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/254768.
Full textTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos
Made available in DSpace on 2018-08-16T00:44:29Z (GMT). No. of bitstreams: 1 Faria_AndreiaFonsecade_D.pdf: 11493166 bytes, checksum: e3cd66f7090b963f62e89ca35a7c600a (MD5) Previous issue date: 2010
Resumo: Os biossurfactantes são compostos amplamente estudados em todo o mundo. Suas características o tornam muito atrativo em relação aos surfactantes sintéticos. Dentre essas características podemos citar, a baixa toxicidade, boa compatibilidade com a pele e olhos, biodegradabilidade e produção a partir de substratos renováveis. No entanto, o custo de produção dos biossurfactantes ainda inviabiliza sua produção em escala industrial. Tradicionalmente, os hidrocarbonetos têm sido os substratos escolhidos para a produção de biossurfactantes e bioemulsicadores. É assumido que a produção de biossurfactantes é induzida para tornar o substrato hidrofóbico acessível a célula. Contudo, substratos solúveis em água também podem ser utilizados para a produção dos surfactantes biológicos. Esses últimos são mais baratos do que os hidrocarbonetos e preferidos em processos fermentativos, devido ao fato de que as fermentações monofásicas são mais simples do que as fermentações bifásicas. Além disso, o uso de hidrocarbonetos são inaceitáveis para a produção de biossurfactantes destinados a aplicações em alimentos, cosméticos e produtos farmacêuticos. Uma grande variedade de matérias-primas estão atualmente disponíveis como substrato orgânico para fermentações industriais, dentre as quais podemos destacar os resíduos agroindustriais. Essas matérias-primas possuem vantagens de serem encontradas em excesso e produzidas em regiões de clima tropical ou temperado. Atualmente, com o aumento da demanda de produção de biodiesel, o glicerol tem ganhado atenção no cenário de bioprocessos, demonstrando ser uma matéria-prima de grande disponibilidade para produção de biomoléculas de interesse industrial. Segundo a Agência Nacional de Petróleo (ANP-Brasil), o Brasil é ranqueado como o maior produtor e consumidor de biodiesel do mundo: 1,2 bilhões de litros/ano em 2008, gerando de 120.000 toneladas de glicerina residual nesse processo. Logo, o presente trabalho teve como objetivo selecionar um substrato orgânico de baixo custo, de forma a tornar viável a produção e comercialização dos biossurfactantes em larga escala. Dentre as 19 linhagens microbianas avaliadas, o microrganismo Bacillus subtilis LSFM_05 foi selecionado para a produção de biossurfactantes, utilizando glicerina residual bruta como substrato orgânico. A temperatura de 32oC e concentração de glicerina de 5% v/v foram designadas como condições ótimas para a produção de biossurfactantes, através do planejamento experimental. A produção dos biossurfactantes foi realizada em fermentador um litro nas rotações de 150, 250 e 350 rev.min -1. A fermentação conduzida à 250 rev.min-1 apresentou melhor desempenho na formação de espuma e produção de biossurfactante. Em seguida, essa condição foi reproduzida em fermentador de 10 litros, que apresentou rendimento de 0,69 g.L-1. Após a execu-ção dos processos fermentativos, os biossurfactantes foram recuperados por precipitação ácida, puri_cados em coluna de adsorção e caracterizados utilizando Espectrometria no Infravermelho com Transformada de Fourier (IV-FT), Espectrometria de Ressonância Magnética (1H e 13C RMN) e Espectrometria de Massa (ESI-MS/MS). O biossurfactante foi caracterizado como uma isoforma do lipopeptídio surfactina, contendo 14 átomos de carbono na cadeia lipídica e sete aminoácidos do anel peptíco. A espectrometria de massa foi capaz de elucidar a composição e sequência de aminoácidos do peptídio cíclico GluOMe(1)/Leu(2)/Leu(3)/Val(4)/Asp(5)/Leu(6)/Leu(7) e os espectros de 1H e 13C - RMN foram de extrema importância para comprovar a esteri_cação do aminoácido ácido glutâmico. O microrganismo Bacillus subtilis LSFM_05 também foi caracterizado como co-produtor de fengicina. A espectrometria de massa apresentou ser uma técnica sensível e rápida para a caracterização dos homólogos A e B de fengicina. A surfactina C14/Leu7 foi avaliada com relação a toxicidade ambiental sobDaphnia similis, apresentando EC50 em 1500 mg.L-1. A surfactina apresentou atividade antiviral contra o vírus envelopado Herpervirus bovino (BoHV-1), inibindo 100% da infectividade do vírus na concentração de 0,25 _M, porém, não apresentou atividade antimicrobiana para os microrganismos avaliados até a concentração de 1mg.mL-1. A surfactina também foi avaliada com relação a citotoxicidade sob _broblastos c3T3 de camundongos, e o valor de EC50 não foi determinado na faixa de concentração estudada, indicando níveis de toxicidade para esse tipo de célula. No âmbito na nanotecnologia, o extrato bruto contendo os biossurfactantes mostrou-se uma ferramenta útil na dispersão de nanotubos de carbono, em água de cultivo de Daphnia, tornando possível o estudo de ecotoxicologia desses nanomateriais
Abstract: In recent years biosurfactants have attracted considerable attention because they o_er several advantages in comparison with synthetic surfactants: low toxicity, greater biodegradability, better environmental compatibility, greater foaming, speci_c activity at extreme temperatures, pH and salinity, and the possibility of being produced from renewable sources and industrial wastes However, biosurfactants have not yet been employed extensively in industry because of their relatively high production and recovery costs. The cost can be reduced by strain improvement, optimizing medium composition by statistical methods or by using alternative inexpensive substrates. Traditionally, hydrocarbons have been the substrates of choice to produce biosurfactants and bioemulsi_ers. It is assumed that surfactant production is induced to render hydrophobic substrates accessible to the cell, but water-soluble substrates such as molasses, cassava waste-water and potato substrates have also been used for biosurfactant production. The latter are cheaper than hydrocarbons and are the preferred substrates, because single-phase fermentation is simpler than biphasic fermentation and in addition the hydrocarbon substrates are unacceptable for many applications, such as in foods, cosmetics and pharmaceutical products. One alternative substrate aimed at decreasing costs in the production of biosurfactants could be the waste glycerol obtained from the biodiesel industry. Brazil is ranked amongst the greatest producers and consumers of biodiesel in the world: 1.2 billion liters /year in 2008, according to the National Petroleum Agency-Brazil (ANP) generating 120,000 tons of waste glycerol in this process. The data described above may support the idea of applying the raw glycerol in the production of biosurfactant on a large-scale. This present study aimed to select an low cost organic substrate, in order to become viable the biosurfactant production on a large scale. Among the 19 microbial strains evaluated, the microorganism Bacillus subtilis LSFM-05 was selected for the biosurfactant production using raw glycerol as organic substrate. The temperature of 32oC and glycerol concentration of 5% v/v were designated as optimal conditions for the production of biosurfactants, by response surface methodology. The production of biosurfactants was carried out by one liter fermentor at 150, 250 and 350 rev.min-1. The 250 rev.min-1 fermentation was the best performance in foaming and biosurfactant production. Then, this condition was reproduced in 10 liter fermentor, with yield of 0.69 g.L-1. After the fermentation processes, the biosurfactants were recovered by acid precipitation, puri_ed by adsorption column and characterized using Infrared Spectroscopy Fourier Transform (FT-IR), Magnetic Resonance Spectroscopy ( 1H and 13C NMR) and Mass Spectrometry (ESI-MS/MS). The biosurfactant was characterized as a surfactin isoform, containing14 carbon atoms in the lipid chain and 7 aminoacids in the peptide portion. The mass spectrometer was able to elucidate the composition and aminoacids sequence in the cyclic peptide GluOMe(1)/Leu(2)/Leu(3)/Val(4)/Asp(5)/Leu(6)/Leu(7). The microorganism Bacillus subtilis LSFM-05 was characterized as a fengycin co-producer. The mass spectrometry have been a sensitive and rapid technique for fengycin homologues characterization. The C14/Leu7 surfactin presented EC50 value of the 1500 mg.L-1 against Daphnia similis in ecotoxicological studies. The surfactin showed antiviral activity against enveloped bovine herpesvirus (BoHV-1), inhibiting 100 % of the infectivity at concentration of 0.25 _M, however, it didn't show antimicrobial activity for microorganisms evaluated until concentration of 1mg.mL-1. The surfactin cytotoxicity in mice _broblasts c3T3 was evaluated as well, and the EC50 value was not determined in the studied concentration range, indicating low levels of toxicity for this cell type. Concerning to applications in nanotechnology, the biosurfactants proved to be a useful tool in the dispersion of carbon nanotubes in standard water cultivation of Daphnia, enabling future studies about the environmental toxicology of these nanomaterials
Doutorado
Doutor em Ciência de Alimentos
Botcazon, Camille. "Etude du mode d'action de composés antifongiques membranotropes naturels sur deux Sclerotiniacées : cas des rhamnolipides et des fengycines." Electronic Thesis or Diss., Compiègne, 2023. https://bibliotheque.utc.fr/Default/doc/SYRACUSE/2023COMP2755.
Full textRhamnolipids (RLs) and fengycins (FGs), are compounds produced by bacteria displaying antifungal properties against the phytopathogenic fungi Sclerotinia sclerotiorum and Botrytis cinerea. However, the induced biocidal effects, and the involved mechanisms are poorly understood in fungi. Due to their amphiphilic properties, a membranotropic mode of action is proposed for these interesting compounds for biocontrol. The present work demonstrates that the two Sclerotiniaceae have opposite sensitivities to RLs and FGs. A microscopy study shows that RLs can induce programmed cell death (PCD) or necrotic cell death in both fungi depending on the concentration whereas FGs systematically induce PCD, probably by triggering autophagy. Lipidomic analyses (fatty acid, phospholipid and ergosterol contents) of S. sclerotiorum and B. cinerea strains differently sensitive to RLs and FGs allow to correlate the lipid contents of the fungi to their sensitivities. These data are used to study the interactions of RLs or FGs on biomimetic plasma membrane models of the two fungi. The dynamics show that the RLs monomers insert into the models without fluidizing them and that the FGs auto-aggregate themselves and insert into some models, inducing fluidization. Ergosterol and phosphatidic acids seems to disfavour this insertion while phosphatidylcholine and phosphatidylethanolamine seem to favour it.This work allows to better understand the antifungal mode of action of RLs and FGs, with a view to develop more effective biocontrol products for crop protection targeting specific pathogens
Rosés, Subirós Cristina. "Solid-phase synthesis of cell-penetrating γ-peptide/antimicrobial peptide conjugates and of cyclic lipodepsipeptides derived from fengycins." Doctoral thesis, Universitat de Girona, 2016. http://hdl.handle.net/10803/393895.
Full textAquesta tesi doctoral s’ha centrat en el desenvolupament d’estratègies sintètiques útils per a l’obtenció de nous pèptids bioactius. Primerament, s’han dissenyat nous pèptids conjugats antitumorals a través de la unió d’un pèptid antimicrobià i un cell-pentrating peptide. Aquesta conjugació augmenta l’activitat antitumoral del pèptid mantenint la toxicitat baixa. Aquests conjugats són interessants pel desenvolupament de nous agents antitumorals. A continuació, s’ha desenvolupat una metodologia per a la preparació de pèptids cíclics derivats de les fengicines. Aquesta metodologia representa la primera estratègia sintètica descrita per a l’obtenció en fase sòlida d’aquesta família de ciclolipodepsipèptids i pot ser fàcilment adaptada per a l’obtenció d’una àmplia varietat d’anàlegs.
Ditmer, Elisabeth M. "Evaluation of the anti-proliverative effect of thelipopeptides iturin A and fengycin of Bacillus spp. and the viral fusionprotein PTD4-VP3 on human cancer and normal cells." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2014. http://hdl.handle.net/10183/117878.
Full textIn cancer cells the apoptotic pathway is damaged by deletion or mutation of important genes, e.g. tumor-suppressor gene p53 or Check2. This causes a loss in cancer cells to undergo controlled cell death resulting in unstopped cell division and tumor growth. Also, many tumors show resistances against the traditional applied treatments like chemo or radiation therapy. Therefore, accompanied or independent cancer treatments based on induced apoptosis or strengthened growth inhibition in cancer cells are under development. The objective of this work was to investigate the anti-proliferative effect on human cancer cells of the lipopeptides iturin A and fengycin obtained from strains of Bacillus spp. as well as of the Avian Gyrovirus II (AGVII) protein -VP3. The VP3 protein of the AGV II was discovered in 2011 and its amino acid sequence showed 32.2% homology and similar functional domains to the chicken anemia virus apoptin (CAV-apoptin), a protein that was proven to induce apoptosis in cancer cells but not in normal cells. Initially, to obtain the VP3 protein for further analysis, the PTD4 sequence, known as a transmission sequence into the cell, was N-terminally added to the VP3 sequence via PCR. After sequencing, the PCR product was cloned into the expression vector pET-SUMO and the final construct transformed into E. coli BL21(DE3)pLyS. After induced protein overexpression and subsequent purification, the PTD4-VP3 protein was quantified and incubated with human cancer-cell cultures. The lipopeptides iturin A and fengycin were produced by Bacillus amyloliquefaciens LBM 5006 and Bacillus sp. P34, respectively. The lipopeptides were purified and added to the cell cultures of human tumor cells. The human non-cancer cell line AS405 (skin fibroblasts) was chosen as control. The protein effect on cell viability was determined via MTT assays. The results showed that the lipopeptides iturin and fengycin as well as the viral peptides PTD4-VP3 (T) and PTD4- VP3 (SM) demonstrated dose-dependent anti-proliferative activity on cancer cells. For the lipopeptides also time-dependent growth-inhibition effect could be detected. A anti-proliferation effect on normal human cells was not excludable but could not clearly be demonstrated. 22 This is the first study validating the anti-proliferative potential of the lipopeptides iturin and fengycin and the viral fusion proteins PTD4-VP3 (T) and PTD4-VP3 (SM) to inhibit cell growth mainly in human cancer cells.
Lin, Ya-Ching, and 林雅靜. "Functions of fengycin synthetase FenA." Thesis, 2003. http://ndltd.ncl.edu.tw/handle/26q7yb.
Full text長庚大學
基礎醫學研究所
91
Fengycin, an antifugal antibiotic, is a cyclic lipopeptidic antibiotics produced by Bacillus subtilis F29-3. Fengycin contains 10 amino acids and is synthesized nonribosomally by peptide synthetases encoded by an operon containing fenC, fenD, fenE, fenA and fenB. In this study, I analyze the functions of fengycin synthetase modules, FenA1, FenA2 and FenA3. FenA1, with a predicted molecular mass of 126 kDa, was expressed in Escherichia coli BL21(DE3)pLysS and was purified by Ni-affinity chromatography. ATP-PPi exchange assay revealed that FenA1 activates proline with an optimun temperature between 25。 to 37。, an optimun pH of 4.5, a Km value of 1 mM and a Kcat value of 0.58 s-1. FenA3, with a predicted molecular mass of 169 kDa, activates tyrosine. FenA2, with a predicted molecular mass of 132 kDa, was expressed as inclusion body in E. coli BL21(DE3) and E. coli BL21(DE3)pLysS. Results presented herein suggest that fengycin synthetase genes and amino acids in fengycin are collinear.
Book chapters on the topic "Fengycine"
Bie, Xiaomei. "Fengycin Production and Its Applications in Plant Growth and Postharvest Quality." In Bio-Based Antimicrobial Agents to Improve Agricultural and Food Safety, 71–119. BENTHAM SCIENCE PUBLISHERS, 2024. http://dx.doi.org/10.2174/9789815256239124010006.
Full textIrie, Mami, and Tomomi Sugiyama. "Potential of anaerobic digestates in suppressing soil-borne plant disease." In Organic Fertilizers - New Advances and Applications [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.1001869.
Full text